Citations

Clear

63 citation(s) found for "Anderson, Jennifer".

Delirium and Long-Term Cognitive Trajectories in Cognitively Unimpaired Adults
St Sauver, Jennifer, Schafer, Marissa

Mayo Clinic

JAMA Neurology | November 2, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1001/jamaneurol.2026.4001 | PMID 42970282 Get It

Importance Delirium is a state of acute confusion characterized by deficits in attention that occurs commonly during hospitalization and is associated with adverse outcomes; however, the association of delirium with longitudinal cognitive trajectories is not fully understood. Objective To evaluate the association of delirium during hospitalization with subsequent development of mild cognitive impairment (MCI), dementia, and longitudinal cognitive trajectories. Design, Setting, and Participants This cohort study used data from participants with hospitalizations in the Mayo Clinic Study of Aging (MCSA) from October 2004 to December 2023. The MCSA is a prospective, population-based longitudinal study of cognitive aging among residents of Olmsted County, Minnesota. Of participants enrolled in the MCSA between 2004 and 2023, individuals who experienced 1 or more hospitalization prior to their last MCSA encounter were included in this study. Participants with dementia at MCSA enrollment or prior to first hospitalization were excluded. Follow-up continued until development of MCI or dementia, last MCSA visit, or the end of the study. Exposure Delirium was identified using a validated natural language processing algorithm applied to clinical notes from hospitalizations, associated emergency department visits, and follow-up within 30 days after hospitalization. Delirium status was modeled as a time-dependent exposure. Main Outcomes and Measures Incident MCI and dementia were assigned through MCSA expert consensus evaluations, including neuropsychological testing performed every 15 months. Association between delirium and development of MCI or dementia was assessed using Cox proportional hazards regression, adjusted for patient age, sex, level of education, and apolipoprotein E (APOE) ε4 allele carrier status; cognitive trajectories were assessed with linear mixed-effects models. Results Of 7030 participants enrolled in the MCSA, 3542 individuals experienced 1 or more hospitalization prior to their last MCSA encounter and were included, and 41 participants with dementia at enrollment or prior to first hospitalization were excluded. The cohort included 3501 participants with at least 1 hospitalization. Median (IQR) age was 74.1 (66.6-80.9) years, 1676 participants (47.9%) were female, median (IQR) level of education was 14 (12-16) years, and 910 participants (26.0%) were APOE ε4 carriers. During a median (IQR) follow-up of 7.2 (4.1-10.4) years, 75 participants (2.1%) had delirium documented within 30 days of hospitalization. Delirium was associated with increased risk of MCI (adjusted hazard ratio [aHR], 3.67; 95% CI, 2.19-6.15) and dementia (aHR, 5.39; 95% CI, 2.94-9.85) and with accelerated decline in longitudinal cognitive testing. Conclusions and Relevance In this cohort study among adults in the MCSA, including those with unimpaired cognition at baseline, delirium during hospitalization was strongly associated with increased risk of MCI and dementia and accelerated cognitive decline in subsequent years.
Retrieval-to-abstraction LLM-assisted literature synthesis: Case demonstrations in digital health technology-enabled randomized controlled trial outcome reporting
Harrison, Taylor B , Hu, Dian , Chen, Fang , Hoy, Matt, St Sauver, Jennifer

Mayo Clinic

PLOS Digital Health | October 9, 2026 | Volume: 5 | Issue: 10 | Pages: e0001768

10.1371/journal.pdig.0001768 | PMID 42853800 Get It

Systematic reviews of randomized controlled trials (RCTs) support evidence-based clinical advancement. Clinical trial reporting guidelines, including CONSORT, establish common data elements that support systematic synthesis of published trial outcomes. However, the rapid rise of digital health technologies presents new challenges for reporting guidelines, and substantial real-world reporting heterogeneity has been observed. Therefore, machine-assisted evaluation of reporting adherence offers a pathway for more agile information management to accommodate the diverse and disruptive nature of digital health technology-enabled RCTs. Here, we propose an accelerated retrieval-to-abstraction literature synthesis framework to conduct article screening, text and table data preprocessing, and full-text review using an unmodified pretrained large language model. We apply this methodology in two digital health technology-enabled RCT case studies evaluating adherence to technology and digital health equity guideline reporting items. Large language model performance was on par with inter-annotator agreement F1 scores (≥0.9) in both screening and information-extraction tasks. These findings support the scalability and rigor of accelerated evidence synthesis and demonstrate the importance of common reporting elements across digital health technology-enabled RCTs.
Differential associations of individual- and neighborhood-level socioeconomic status with mortality in dementia: Findings from the Mayo Clinic Study of Aging
Lin, Jie , Vassilaki, Maria , Sauver, Jennifer St., Petersen, Ronald C., Wi, Chung Il, Juhn, Young J., Sham, Yuk , Sohn, Sunghwan , St Sauver, Jennifer, Sham, Yuk , Sauver, Jennifer L. St. , Petersen, Ronald C. , Wi, Chung‐Il , Juhn, Young J. , Chen, Jun

Mayo Clinic

Journal of Alzheimer’s Disease | September 3, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/13872877261482043 | PMID 42690834 Get It

Background Alzheimer's disease (AD) and related dementias are leading causes of death worldwide. While socioeconomic status (SES) is a critical determinant, its impact on mortality after diagnosis remains understudied. Objective To investigate the roles of neighborhood-level and individual-level SES in predicting mortality risk among older adults with incident dementia. Methods We analyzed data from 924 participants with incident dementia from the Mayo Clinic Study of Aging (N = 6909), a cohort with clinical follow-up visits every 15 months. We assessed mortality risk using Cox's time-varying survival regression, adjusting for time-fixed and time-varying covariates. Primary predictors were neighborhood-level SES (Area Deprivation Index [ADI]) and individual-level SES (housing-based SES index [HOUSES], education, and occupation). We also applied a random survival forest model to assess the predictive contribution of SES indicators and identify influential predictors. Results 857 participants (92.7%) died, with a median time from dementia diagnosis to death of 29 months (IQR: 12–54). Lower SES measured by HOUSES was associated with increased mortality risk (HR 1.28, 95% CI 1.07–1.52). Conversely, ADI, education, and occupation were not associated with mortality. Male sex, older age, congestive heart failure and diabetes were associated with higher mortality risk. In predictive analysis, HOUSES ranked among the top 10 contributors to mortality risk. Conclusions Among older adults with dementia, lower HOUSES was associated with higher mortality risk beyond neighborhood-level deprivation, education, and occupation. Integrating this housing-based individual-level SES measure into dementia care planning may help identify patients with greater socioeconomic vulnerability and inform mortality risk stratification.
Quantifying the Uncertainty and Risk Contributions of Activities of Daily Living Features in Dementia Prediction
Bag, Souvik, Jeon, Eunji , Garg, Muskan, Vassilaki, Maria, Petersen, Ronald C., Sauver, Jennifer St., Sohn, Sunghwan , St Sauver, Jennifer, Garg, Muskan , Liu, Xingyi , Vassilaki, Maria , Petersen, Ronald C., Sauver, Jennifer L. St.

Mayo Clinic

2026 IEEE 14th International Conference on Healthcare Informatics (ICHI) | August 12, 2026 | Volume: No volume available | Issue: No issue available | Pages: 291-296

10.1109/ichi69079.2026.00046 | PMID 42602482 Get It

Multi-Omics Study of Ancestry in Adults with Intracranial Cancers – Glioma (MOSAIC)
Noor, Humaira, Tsavachidis, Spiridon, Fukumura, Kazutaka , Ostrom, Quinn T., Muzny, Donna M. , Korchina, Viktoriya , Norberg, Lisa, Desjardins, Annick , Horbinski, Craig, Tadimeti, Vasudev, Mandel, Jacob, Wrensch, Margaret, Hu, Jianhong, Doddapaneni, Harsha, Liu, Xiuping , Momin, Zeineen , Motewar, Pryanka, Armstrong, Georgina , Woods, Meghan , Bernstein, Jonine L. , Amos, Christopher I., Huse, Jason T., Bondy, Melissa L. , Ostrom, Quinn T. , Walsh, Kyle M. , Peng, Bo , Nabors, Burt , Norberg, Lisa M. , Ritchie, Jennifer , Horbinski, Craig , Perez, Alejandro, Mandel, Jacob , Wrensch, Margaret , Bale, Tejus , Orlow, Irene , Hu, Jianhong , Doddapaneni, HarshaVardhan , Amos, Christopher I. , Huse, Jason T.

Mayo Clinic

No container title available | June 26, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.06.24.733669 | PMID 42395459 Get It

ABSTRACT Background Most genomic studies of adult-type diffuse gliomas have focused on predominantly European ancestry populations, limiting the generalizability of molecular classifications and precision medicine approaches. We assembled a multi-institutional glioma cohort of diverse patients to investigate how germline ancestry, molecular subtypes, and mutational processes shape tumor biology and clinical outcomes. Methods We analyzed 1,102 adults with WHO 2021–classified diffuse gliomas (IDH-mutant, 1p/19q-codeleted oligodendroglioma; IDH-mutant astrocytoma; IDH-wildtype glioma) from seven U.S. institutions. Whole-exome sequencing (WES) of FFPE tumors identified somatic alterations and COSMIC SBS v3.2 mutational signatures. Genetic ancestry was estimated from WES using 1000 Genomes reference populations. Overall survival was assessed using Kaplan–Meier and multivariable models. Results The cohort included 66.9% European (EUR), 21.1% Admixed American/Hispanic (AMR), 10.3% Admixed African (AFR), and 1.6% Asian (AS) ancestry. Survival followed expected molecular hierarchy (median overall survival: oligodendroglioma 15.7 years, astrocytoma 10.6 years, IDH-wildtype glioma 1.9 years). Within oligodendroglioma, AMR patients showed improved survival versus EUR (HR 0.67, 95% CI 0.48–0.94; p=0.011), with similar trends across subtypes. Somatic profiling confirmed canonical subtype-defining alterations and revealed higher ATRX alterations in AFR and AMR IDH-wildtype tumors compared with EUR. ATRX alterations were associated with improved survival only in AFR (p=0.003). Mutational signature analysis identified subtype-specific signatures, including therapy-associated signatures. Chemotherapy-related signatures were more frequent in EUR and AMR than in AFR. Conclusions This ancestrally diverse glioma cohort confirms established molecular classifications and identifies ancestry-associated differences in survival, somatic alterations, and mutational processes, indicating the critical need for broad representation to inform precision neuro-oncology. Key Points A multi-institutional glioma cohort validates subtype and survival patterns across ancestries. Therapy-associated mutational signatures differ by ancestry, suggesting distinct treatment-related mutational processes. Admixed American patients show improved survival, particularly in oligodendroglioma. Importance of the Study Most genomic studies of adult-type diffuse glioma have focused on populations of predominantly European ancestry which limits the ability to examine variation in tumor biology and clinical outcomes across populations. In this study, we assembled one of the largest ancestrally diverse cohorts of molecularly characterized adult diffuse gliomas, integrating germline ancestry inference with tumor whole-exome sequencing and mutational signature analysis. We confirm that established molecular classifications and survival hierarchies remain robust across ancestry groups. However, we also identified ancestry-associated differences in survival within specific tumor subtypes, higher ATRX alteration frequencies in African American and admixed American patients with IDH-wildtype tumors, and variation in therapy-associated mutational signatures across ancestry groups. These findings highlight the importance of incorporating population differences into genomic studies of glioma and provide a resource for future multi-ancestry investigations of glioma risk, tumor evolution, and treatment response, ultimately supporting more inclusive precision neuro-oncology.
Elective genomic sequencing for adults in research, clinical and commercial contexts
Linderman, Michael D. , Adelson, Sophia , Berro, Tala , Crawford, Scott , Cunningham, Tshaka J., Esplin, Edward D. , Ewing-Crawford, Altovise T, Nielsen, Daiva E. , Andrighetti, Heather, Bleyl, Steven B., Haverfield, Eden , Hegde, Madhuri , Konstantinos, Lazaridis N, Leonard, Debra G. B. , May, Thomas , McGinniss, Molly, Pandya, Vaibhav, Schadt, Eric E. , Zettler, Bethany , Team, PeopleSeq Study, Adelson, Sophia M , Berro, Tala M , Crawford, Scott D , Esplin, Edward D , Nielsen, Daiva E , Pereira, Stacey , Schmidlen, Tara , Haverfield, Eden V , Hegde, Madhuri , Kruszka, Paul , Leonard, Debra , May, Thomas , Schadt, Eric E , Tzovaras, Bastian Greshake , Zettler, Bethany , McGuire, Amy L , Green, Robert C. , Berro, Tala M., Anderson, Jennifer L., Cunningham, Tshaka, Ewing, Altovise T. , Nielsen, Daiva E., Church, George M. , Konstantinos, Lazaridis N., McGinniss, Molly A. , Schadt, Eric E., Green, Robert C., Juusola, Jane , McWalter, Kirsty , Esplin, Ed, Haverfield, Eden, Hazell, Allison, Gu, Jessica, Hogan, Jennifer, Church, George , Ball, Mad Price , McGinnis, Molly, Schadt, Eric, Linderman, Michael, McGuire, Amy, Christensen, Kurt D. , Caskey, Thomas, Zoltick, Emilie S. , Crawford, Scott, Young, Robert, Hunsanger, Jillian, Bradley, Sophia, Cunningham, Tshaka, Roberts, Scott, Ricks‐Santi, Luisel , Lillard, James, Washington, Kareem N., Johnson, Anthony

Mayo Clinic

No container title available | June 19, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.06.09.26355296 | PMID 42369514 Get It

Abstract Purpose Elective genomic sequencing (EGS) returns monogenic disease findings in multiple genes, including potentially novel variants, and may also provide participants with carrier status, pharmacogenomic and other health-related information. The PeopleSeq Study assessed participants’ motivations for and concerns about EGS and the associated clinical and psychosocial outcomes across diverse EGS providers. Methods We administered a shared questionnaire to participants who chose to undergo EGS via 18 academic, clinical, or commercial EGS platforms. Results We enrolled 1575 participants, of whom 1147 (72.8%) completed a questionnaire after receiving their EGS results. A majority (60.3%) of the participants who completed a post-result questionnaire self-reported receiving results they assessed as important, including negative findings, and 75.9% reported a form of health-related utility. Among a subset (19.4%) who shared their EGS reports, 16.6% (37 of n =223) received a monogenic finding and self-reported results deemed “important” were consistent with EGS reports. Most participants (74.1%) discussed their results with their family, but fewer discussed their results with a healthcare provider other than the site team (41.7%) or had one or more medical visits as a direct result of their EGS testing (23.1%). Participants expressed diverse motivations for EGS, with 91.4% expressing interest in their personal disease risk and 54% who expressed quasi-indication-based motivations related to family medical history. Individuals motivated by family history reported important results at a significantly higher rate. Conclusions Early adopters of EGS are motivated by general interest in their health as well as quasi-indication-based considerations such as family history. A majority of participants learned results they considered medically important, but a much smaller segment engaged healthcare providers with their results.
Glial Fibrillary Acidic Protein in Multiple System Atrophy (P10-7.003)
Schmeichel, Ann, Misra, Pinaki, Griffiths, Shannen, Anderson, Jennifer, Sletten, David, Gehrking, Tonette, Gehrking, Jade, Low, Phillip, Singer, Wolfgang , Schmeichel, Ann M., Misra, Pinaki , Sletten, David M., Gehrking, Tonette L., Gehrking, Jade A., Vemuri, Prashanthi , Low, Phillip A.

Mayo Clinic

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000217890 Get It

Optimizing tuberculosis post-exposure follow-up among healthcare personnel using a risk-based approach
Samreen, Ayesha, Swift, Melanie D. , Breeher, Laura E. , Apenhorst, Debra, Rasmusson, Jenna, Loeffler, April, Anderson, J. Simon, Shah, Aditya , Samreen, Ayesha , Samreen, Ayesha , Apenhorst, Debra K, Rasmusson, Jenna M., Loeffler, April R, Anderson, Jennifer A, Shah, Aditya S , Swift, Melanie D , Breeher, Laura , Anderson, Jennifer A.

Mayo Clinic

Infection Control & Hospital Epidemiology | February 2, 2026 | Volume: 47 | Issue: 5 | Pages: 530-532

10.1017/ice.2026.10403 | PMID 41623146 Get It

Abstract Healthcare personnel (HCP) are at risk for occupational exposure to tuberculosis. Current guidelines for managing exposed HCP are broad and resource intensive. Based on review of our internal data, we propose a risk-based stratification approach to streamline exposure follow-up testing and optimize resource utilization.
Uncovering the Role of Neuropsychiatric Symptoms in Cognitive Impairment Progression
Jeon, Eunji , Garg, Muskan , Vassilaki, Maria , Petersen, Ronald C., Sohn, Sunghwan , St Sauver, Jennifer, Liu, Xingyi , Sauver, Jennifer L. St. , Petersen, Ronald C.

Mayo Clinic

2025 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) | January 29, 2026 | Volume: No volume available | Issue: No issue available | Pages: 5454-5462

10.1109/bibm66473.2025.11356407 | PMID 41716847 Get It

Hide and Seek: Privacy-Preserving Artificial Intelligence with a Feasibility Study in Rare Disease Diagnosis
Rajaganapathy, Sivaraman , Sauver, Jennifer St., Vairo, Filippo Filippo Pinto e, Iyer, Prasad G. , Liu, Hongfang , St Sauver, Jennifer, Pinto E Vairo, Filippo, Fan, Jungwei W, Sauver, Jennifer L. St. , Liu, Hongfang , Fan, Jungwei

Mayo Clinic

No container title available | January 18, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.01.15.26344228 | PMID 41646657 Get It

Abstract Background Integrating advanced artificial intelligence (AI) into clinical decision-support often requires the sharing of sensitive patient data with external services, raising privacy concerns. Homomorphic encryption (HE) allows computing directly on encrypted data, without revealing the underlying patient information. Objectives To develop a large language model (LLM)-assisted diagnosis framework while preserving patient privacy in the clinical text analysis, by leveraging HE and using rare disease (RD) diagnosis as a representative application. To demonstrate HE does not hinder the system performance. Materials and Methods Texts from patient histories and a RD knowledge base were embedded by LLMs into vectors, then encrypted using HE to obscure private information while retaining the semantic nuances. Diagnostic recommendations were generated by computing and ranking the similarities between the patient history and RD vectors in the encrypted space. The system was evaluated using 50 synthetic case reports (5 RDs, each with 10 reports). Results Applying HE did protect private information from reverse-embedding attacks. HE imposed little disruption to the diagnostic accuracy, with normalized discounted cumulative gains (nDCG) of 0.6108 ± 0.3412 (encrypted) versus 0.6083 ± 0.3415 (unencrypted). The accuracy and computational performance were tunable and consistent, as demonstrated across five different LLMs. Discussion Our privacy-preserving framework opens tremendous opportunities toward hosting and serving powerful AI solutions across institution boundaries, which would remove the need for local deidentification and incentivize users to access secure external decision-support services. Conclusions Integrating HE with LLM retrieval can promote the dissemination of nonredundant, high-capacity AI services by preserving both privacy and accuracy.